argenx SE (ARGX)
376.43
-1.59
(-0.42%)
USD |
NASDAQ |
Apr 15, 16:00
376.12
-0.31
(-0.08%)
After-Hours: 20:00
argenx Shareholders Equity (Quarterly): 4.098B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.098B |
| June 30, 2023 | 2.858B |
| December 31, 2022 | 2.814B |
| June 30, 2022 | 2.970B |
| December 31, 2021 | 2.534B |
| June 30, 2021 | 2.952B |
| December 31, 2020 | 1.674B |
| June 30, 2020 | 1.818B |
| December 31, 2019 | 1.180B |
| June 30, 2019 | 756.55M |
| June 30, 2019 | 756.55M |
| December 31, 2018 | 615.87M |
| Date | Value |
|---|---|
| June 30, 2018 | 384.97M |
| June 30, 2018 | 384.97M |
| December 31, 2017 | 413.81M |
| June 30, 2017 | 171.88M |
| December 31, 2016 | 66.65M |
| June 30, 2016 | 83.87M |
| December 31, 2015 | 40.76M |
| June 30, 2015 | 49.56M |
| December 31, 2014 | 60.90M |
| June 30, 2014 | 23.88M |
| March 31, 2014 | 27.33M |
| December 31, 2013 | 29.97M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
756.55M
Minimum
Jun 2019
4.098B
Maximum
Dec 2023
2.219B
Average
2.534B
Median
Dec 2021
Shareholders Equity (Quarterly) Benchmarks
| TC BioPharm (Holdings) PLC | 3.421M |
| Trinity Biotech PLC | -17.49M |
| Adaptimmune Therapeutics PLC | 39.51M |
| Merus NV | 356.34M |
| Biophytis SA | -4.264M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.542B |
| Total Liabilities (Quarterly) | 444.95M |
| Current Ratio | 9.749 |